Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04008329

A Registered Cohort Study on Amyotrophic Lateral Sclerosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
First Affiliated Hospital of Fujian Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without effective therapy. This registered cohort study will provide further insights into the clinical course of ALS, and investigate disease-relative risk factors and the genetic background of Chinese ALS patients.

Detailed description

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND), which is characterized with highly clinical heterogeneity and no effective treatment is available now. The purpose of this registered cohort is to observe the natural history of ALS patients in China, and then identify some factors correlated with disease progression. Besides, ALS-related gene mutations will be screened and explore novel disease causing gene as well.

Conditions

Timeline

Start date
2019-07-05
Primary completion
2029-07-01
Completion
2059-07-01
First posted
2019-07-05
Last updated
2021-03-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04008329. Inclusion in this directory is not an endorsement.

A Registered Cohort Study on Amyotrophic Lateral Sclerosis (NCT04008329) · Clinical Trials Directory